What You Should Know: - Accenture published Fast-Forwarding Healthcare through Data Collaboratives Report to discover how best health ecosystem players access data to fast-forward healthcare. - Data generated by technical and scientific advances, like connected health devices, consumer health and medical-grade digital apps, individual multi-omics profiling data and the move to cloud storage, holds great promise for accelerated healthcare progress and precision medicine, and data
Read More
Impact of Precision Medicine| News, Policy, Analysis, Insights - HIT Consultant
PathGroup Expands Operations with Proscia Concentriq Dx
What You Should Know: - PathGroup, one of the largest providers of anatomic, clinical, digital, and molecular pathology services in the United States, is expanding its operations with Proscia's software platform (Concentriq® Dx) to further enhance the delivery of faster, higher quality results for millions of patients, helping to better inform treatment decisions. - PathGroup currently supports more than 15,000 referring physicians and over 200 hospital
Read More
Tempus, Pfizer Partner to Advance Oncology Therapeutic Development
What You Should Know: - Today, the AI-powered genetic testing and precision medicine company Tempus announced that it has signed a significant strategic agreement with Pfizer to more precisely gather insights that will inform novel drug discovery and development in oncology. - Through this collaboration, Pfizer has access to Tempus’ AI-enabled platform and its library of de-identified, multimodal data to uncover insights that will power therapeutic development in oncology. -
Read More
Tempus Forms Multi-omics Collaboration With Actuate Therapeutics
What You Should Know: - Tempus, the $10B artificial intelligence and precision medicine company, announced their first multi-omics collaboration with Actuate Therapeutics, in which datasets of different omic groups – genomics, transcriptomics, epigenomics, and others are combined during analysis to improve research and enable new discoveries, including ones that would have been missed with a single method alone. - This multi-omics approach is being used by Actuate Therapeutics in support
Read More
Unintended Bias in AI-Driven Healthcare Applications
What You Should Know: - Over the past few years, Artificial Intelligence (AI), and more specifically, Machine Learning (ML) technology, have experienced rapid adoption in the healthcare space as tools for diagnosis and decision-making. Such tools are intended to address challenges in the healthcare system to both processes and put into practice the proliferating medical findings, and also to support delivery of the promise of personalized and precision medicine. - Unintended bias in AI and
Read More
5 Things Every Smart Operating Room Should Prioritize – Surgery
The healthcare industry is in the middle of deep digital transformation across every aspect of the patient journey. Technology has always been important in healthcare, but COVID-19 has accelerated advancements, improving the way care is delivered. The pandemic also increased patient interest in being more involved in their healthcare decisions. And when patients are more involved, they are typically more satisfied with their experience and have better health outcomes. From remote patient
Read More
Boosting Clinical Trial Recruitment Requires Humanity – and Technology
Clinical trials should be a time of promise for better patient outcomes, as they explore new ways to potentially help patients suffering from a variety of conditions. Instead, this phase of treatment development is often met with exasperation as patients, researchers, and drug developers deal with the many barriers to clinical trial recruitment and access. There are two central – and intrinsically linked – problems with the current state of clinical trial recruitment in the U.S.:
Read More
7 Life Sciences Executive Predictions to Watch in 2023
Tracy Curley, CFO and interim CEO at iSpecimen Focusing on the macroeconomic environment, which remains impacted by the lingering COVID-19 pandemic, there continues to be uncertainty about the strength of the global, Asia Pacific, UK and US economies. High-interest rates and a potential recession remain a concern for all market participants. At ISPC, we are closely monitoring the pace of specimen transactions. We believe that this industry can be resilient through a continued economic
Read More
Startup Velsera Launches to Advance Precision Health Through Data-Driven Solutions
What You Should Know: - New company Velsera was announced at the J.P. Morgan Healthcare Conference supported by thematic-focused impact fund Summa Equity (“Summa”). - Velsera sets out to amplify the impact of clinicians, researchers and scientists for the benefit of patients around the world. Velsera creates a software platform out of science, technology, and informatics, making data actionable, accelerating the pace and potential of multi-omics. - Velsera, headquartered in
Read More
AWS Launches Amazon Omics for Precision Medicine
What You Should Know: - AWS announced the launch of a new service, Amazon Omics, to help bioinformaticians, researchers, and scientists store, query, and analyze genomic, transcriptomic, and other omics data and generate insights to improve health and advance scientific discoveries. - The explosion of “omics” data, such as genomic, transcriptomic, and proteomic data, is driving a new understanding of biology at the molecular level. This, in combination with
Read More
